386849001: Olanzapine (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Central nervous system agent (substance)\Psychoactive substance\Psychotropic agent (substance)\Anti-psychotic agent (substance)\Olanzapine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Dibenzoxazepine compound (substance)\Olanzapine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olanzapine (substance)	Is a	Dibenzoxazepine derivative antipsychotic agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine (substance)	Is a	classe d'allergènes	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine (substance)	Is a	Dibenzoxazepine compound (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine (substance)	Is a	Anti-psychotic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Olanzapine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine measurement	Component	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 5mg dispersible tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 10 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 15mg disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 20 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine oral disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluoxetine and olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10mg powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing olanzapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 300mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 210mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 405mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine embonate (substance)	Is a	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 5 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 7.5 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 2.5 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 20 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 15 mg oral tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine pamoate (substance)	Is a	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 5 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 7.5 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 2.5 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Olanzapine 20 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 15 mg oral tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluoxetine and olanzapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only fluoxetine and olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Olanzapine only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only olanzapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluoxetine and olanzapine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Olanzapine embonate (substance)	Is modification of (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine pamoate (substance)	Is modification of (attribute)	False	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Olanzapine 5mg dispersible tablet (substance)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 5mg dispersible tablet (substance)	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg orodispersible tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg orodispersible tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 20 mg orodispersible tablet	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 20 mg orodispersible tablet	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine-containing product in oromucosal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only olanzapine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluoxetine (as fluoxetine hydrochloride) 25 mg and olanzapine 6 mg oral capsule	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluoxetine (as fluoxetine hydrochloride) 25 mg and olanzapine 6 mg oral capsule	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Olanzapine 10 mg powder for solution for injection vial	Has precise active ingredient	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Olanzapine 10 mg powder for solution for injection vial	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely olanzapine (as olanzapine embonate) 300 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	Has basis of strength substance (attribute)	True	Olanzapine (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Reference Sets

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461027011	Olanzapine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480964017	Olanzapine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461027011	Olanzapine (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461027011	Olanzapine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480964017	Olanzapine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1480964017	Olanzapine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
60231000195117	olanzapina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
75671000195117	Olanzapin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
829171000172117	olanzapine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
829171000172117	olanzapine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
60231000195117	olanzapina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
75671000195117	Olanzapin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module